Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Agen Biomedical
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult man or woman, aged ≥18 years, presenting with suspected lower-limb initial or recurrent DVT.
Moderate or high pre-test probability (PTP) for DVT.
Onset of symptoms occurred within the last 7 days.
Women of childbearing potential to have a negative pregnancy test as determined by measuring serum β-hCG levels at time of study enrolment.
You may not be if
Receiving anticoagulant therapy at therapeutic doses for \>3 days.
Life expectancy \<3 months.
Patient with a renal transplant.
Renal dysfunction: serum creatinine \>1.5x upper limit of normal range.
Hepatic dysfunction: serum transaminases \>3x upper limit of normal range.
Current pregnancy or lactation; or conception intended within 90 days of enrolment
Of childbearing potential and unwilling to use adequate contraception for 30 days following enrolment
Unable to undergo lower limb ascending venography on symptomatic leg(s).
Allergy or other contraindication to intravenous contrast dye.
Prior exposure to murine or humanized antibodies.
Prior imaging studies with: I131 within the last month; In111 or Ga67 within the last 2 weeks; Tc99m labelled RBCs, WBCs or albumin within the last 48 hours; Tc99m or F18 within the last 24 hours; prior non-imaging, non-therapeutic nuclear medicine studies with I131 (eg., 24-hour RAI uptake) within the last 2 weeks.
Previous participation in the present study.
Geographic inaccessibility that precludes follow-up visits.
Patient is unwilling or unable to provide informed consent.
Patient is unsuitable for the study, at the Study Investigator's discretion.
Clareo Health | Clinical Trial to Evaluate the Accuracy of [99mTc] ThromboView in the Detection of Deep Vein Thrombosis
